IBD

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/86

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 11:55 AM on 3/26/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

87 Terms

1
New cards

What is Inflammatory Bowel Disease (IBD)?

A spectrum of remitting and relapsing, chronic, inflammatory intestinal conditions causing significant GI symptoms.

2
New cards

What are the two major subtypes of IBD?

Ulcerative Colitis (UC) and Crohn's Disease (CD).

3
New cards

Where is Ulcerative Colitis (UC) primarily located?

Mostly limited to the colon and rectum (95%).

4
New cards

Where is Crohns Disease primarily located?

any portion of the GI tract

almost always affects the terminal ileum and cecum

ileocecal valve

5
New cards

What is the first-line treatment for mild-to-moderate Ulcerative Colitis?

Mesalamine-based therapy.

6
New cards

Is Mesalamine generally used in Crohn's Disease?

No

7
New cards

What is Sulfasalazine?

A prodrug that contains 5-ASA linked to sulfapyridine by an azo bond

8
New cards

What is the function of the azo bond in Sulfasalazine?

It prevents absorption in the stomach or small intestine, releasing active 5-ASA in the colon after colonic bacterial azoreductase cleave the bond

9
New cards

Name two second generation prodrug 5-ASA compounds.

Olsalazine and Balsalazide.

10
New cards

Role of coated mesalamine

delayed release, releases drug throughout the GI tract

11
New cards

Role of PH sensitive mesalamine

◦Releases drug in the small intestine and colon

12
New cards

A mesalamine suppository works where?

rectum

13
New cards

A mesalamine enema works where?

distal colon

14
New cards

what is canasa?

mesalamine suppository

15
New cards

what is asacol?

delayed release resin tablet

16
New cards

what is pentasa?

microgranule controlled-release capsule

17
New cards

what is lialda?

MMX formulated pH-dependent polymer film coated tablet

18
New cards

what is aspriso?

enteric coated granules in polyermatrix

19
New cards

where do apriso, balsalazide, lialda, olsalazine, and delzicol work>

proximal colon

20
New cards

where does asacol HD work?

all the way to terminal ileum

21
New cards

where does pentase work?

all the way to jejunum

22
New cards

What are the adverse effects associated with Sulfasalazine?

Nausea, GI upset, headaches, arthralgias, myalgias, bone marrow suppression, malaise, impaired folate absorption, and hypersensitivity to sulfapyridine.

23
New cards

What percentage of patients discontinue Sulfasalazine due to adverse effects?

Up to 40%.

24
New cards

What patients have higher risk of ADEs with sulfasalazine?

◦Slow acetylators have a higher incidence of adverse effects than fast acetylators

25
New cards

How do corticosteroids function in the treatment of IBD?

They suppress acute inflammation and modulate the immune system by inhibiting cytokine production.

26
New cards

How can corticosteroids be administered for IBD?

Parenterally, orally, or rectally.

27
New cards

What is unclear about the effects of corticosteroids in IBD?

Whether the most important effects are systemic or local (mucosal).

28
New cards

corticosteroids role in IBD

Used for the treatment of active UC or CD to induce remission

◦Should not be used chronically to maintain disease remission

29
New cards

Corticosteroids MOA

modulates immune system and inhibits production of cytokines and mediators

30
New cards

corticosteroids used for sevre vs mild IBD

severe disease: burst and taper 1-2 weeks

◦Oral- Prednisone and prednisolone

◦IV- methylprednisolone

Mild to Moderate: topical hydrocortisone, budenoside, oral/topical enteric coated budenoside

31
New cards

enteric coated budenoside ADME

◦Undergoes extensive first pass metabolism that reduces systemic absorption

◦Drug is delivered primarily at the ileocecal junction

can be used for up to 8 weeks

32
New cards

name the synethic glucocorticoid used for retaining UC/Crohns remission

budenoside

*not preferred to be used for maintenance

33
New cards

budenoside ADEs

HA, acnea, nausea, CYP3A4

34
New cards

What are the immunomodulators used in IBD?

Azathioprine, 6-mercaptopurine (6-MP), and methotrexate.

<p>Azathioprine, 6-mercaptopurine (6-MP), and methotrexate.</p>
35
New cards

What is the purpose of immunomodulators in IBD treatment?

Monotherapy or adjunctive therapy for patients not responding to mesalamine-based therapy, can help maintain remission achieved with corticosteroids (steroid-sparing effect)

36
New cards

Adjunct to biologics and anti-integrin therapies to add efficacy and reduce risk of antibody formation

immunomodulators

37
New cards

Are immunomodulators used for induction therapy?

no - takes 6 months

38
New cards

What is the MOA of azathioprine and 6-MP?

Purine antimetabolites with immunosuppressive properties

Impair purine biosynthesis and inhibit cell proliferation

39
New cards

What should be tested before initiating azathioprine treatment?

TPMT activity to assess risk of bone marrow suppression

40
New cards

azathioprine DDI caution

xanthine oxidase inhibitors

41
New cards

azathioprine ADE

◦Idiosyncratic

◦Pancreatitis (5%)

◦N/V, fever, rash arthralgias

- bone marrow suppression

42
New cards

What is the MOA of methotrexate?

Inhibition of dihydrofolate reductase, reducing thymidine and purines production.

◦Used in many chronic inflammatory conditions as maintenance therapy

43
New cards

Methotrexate onset of action

8 weeks

44
New cards

Methotrexate administration

PO, IM, or SubQ once weekly

45
New cards

What are common adverse effects of methotrexate at higher doses?

Bone marrow suppression, megaloblastic anemia, alopecia, mucositis.

*folate supplentation reduces risk

46
New cards

cyclosporine MOA

Calcineurin inhibitor

47
New cards

What is the primary role of cyclosporine in IBD?

Limited to treating specific problems like fistulous complications or severe UC failing corticosteroids over short term

48
New cards

What are the significant adverse effects of cyclosporine?

Renal toxicity, cardiovascular risks, hyperglycemia, gum hyperplasia, hepatotoxicity, hyperuricemia, hirsuitism, hyperlipidemia, hypertension.

*CYP3A4

49
New cards

Name the classes of biologic agents used in IBD.

TNF-α inhibitors

leukocyte adhesion inhibitors

anti- IL23

Anti-IL12/IL23

50
New cards

Which TNF-a inhibitors are used fro both UC and Crohn's

◦Infliximab:

Adalimumab

51
New cards

Which TNF-a inhibitors are used for only Crohn's?

Certolizumab

52
New cards

Which TNF-a inhibitors are used for only UC?

Golimumab

53
New cards

What is the therapeutic effect of TNF-α inhibitors in Crohn's disease?

They lead to improvement in 60% and disease remission in 30% of patients with moderate to severe crohns disease

*Median time to clinical response is 2 weeks

54
New cards

What are the 'big four' things to worry about with TNF-alpha therapy?

Infection risk, malignancy, heart failure, and hypersensitivity disorders.

55
New cards

What should be tested prior to initiating TNF-alpha therapy?

Screening for tuberculosis (TB) and hepatitis B.

56
New cards

name the leukocyte adhesion inhibitors (anti-integrins)

natalizumab

vedolizumab

57
New cards

natalizumab MOA

◦Anti- α4 integrin that binds to CNS-tropic and gut-tropic T cells

58
New cards

Vedolizumab MOA

◦Anti- α4 integrin that binds to only gut-tropic T cells

59
New cards

What is the role of leukocyte adhesion inhibitors (anti-integrins) in IBD?

◦In patients who have failed or cannot tolerate TNF inhibitors

60
New cards

ADEs of anti-integrin therapy

◦Infusion-related reactions

◦Hypersensitivity

61
New cards

What is a serious risk associated with Natalizumab?

Risk of Progressive Multifocal Leukoencephalopathy (PML).

62
New cards

What are the common adverse effects of Vedolizumab?

Headache and nasopharyngitis.

63
New cards

screening specification for anti-integrin therapy

Do not need to screen for TB or Hepatitis with these agents

* Risk of lymphoma is much less than with the TNF inhibitors

64
New cards

Name three IL-23 agents.

Risankizumab, Mirikizumab, and Guselkumab.

*Mike, Gus, and Ris are all 23

65
New cards

Name the IL-12/IL-23 agent

ustekinumab

66
New cards

IL-inhibitors MOA

monoclonal antibody that binds to the p40 subunits preventing activation of interlukin 23 +/-12 which are pro-inflammatory cytokines on lymphocytes

67
New cards

What are IL-23 agents used for in Crohn's disease?

They are used as second-line therapy crohns disease

68
New cards

What are common adverse effects of IL-inhibitor therapy?

Hypersensitivity, infusion-related reactions, TB (test prior), HA, fatigue, injection site reaction, and herpes infections.

69
New cards

What antibiotics are commonly used in Crohn's disease?

Metronidazole and Ciprofloxacin.

70
New cards

What is the mechanism of action of antibiotics in crohns disease?

It may interrupt the inflammatory process directed at the endogenous flora.

71
New cards

when are antibiotics often added to crohns therapy?

◦Often used in patients when fistulas or abscesses are present

72
New cards

What is a potential complication of ileal pouch anal anastomosis (IPAA) in UC?

Pouchitis.

73
New cards

What are common adverse effects of Ciprofloxacin?

Nausea, vomiting, diarrhea, headache, dizziness, and phototoxicity, QT prolongation, increases levels of warfarin and theophylline

74
New cards

Ciprofloxacin BBW

Tendonitis and tendon rupture.

75
New cards

What are common adverse effects of Metronidazole?

Gastrointestinal upset, metallic taste, dark urine, vertigo, ataxia, disulfiram-like reaction, incteractions with warfarin, phenytoin, phenobarbitol

76
New cards

What is the initial treatment for distal mild to moderate active UC?

Oral/topical 5-ASA agents.

 Consider reducing ASA to lowest possible effective dose

77
New cards

What is the initial treatment for extensive mild to moderate active UC?

oral mesalamine or budesonide

78
New cards

What is the treatment for moderate to severe active UC?

Budesonide or high-dose prednisone, possibly combined with infliximab or vedolizumab +/- AZA

*need to quickly suppress inflamation

79
New cards

 If taking budesonide, try to stop after _ weeks after remission achieved

8

80
New cards

What is the treatment for acute severe or fulminant UC?

Hospitalization with methylprednisolone or hydrocortisone.

81
New cards

What is the treatment for acute severe or fulminant UC with no response to steroids?

infliximab or cyclosporine

82
New cards

What is the treatment for mild to moderate active Crohn's disease - extensive?

Sulfasalazine

83
New cards

What is the treatment for mild to moderate active Crohn's disease - perianal?

metronidazole +/- infliximab

84
New cards

What is the treatment for mild to moderate active Crohn's disease - small bowel?

budesonide

85
New cards

Treatment for Moderate to Severe Active Crohn's Disease

◦Prednisone + infliximab

◦Adalimumab

◦Vedolizumab +/- MTX

◦AZA/6-MP

* off 2-4 weeks after response achieved

86
New cards

Treatment for Moderate to Severe to fulminant

◦Hospitalization

◦Steroids

◦Infliximab prior to surgery as last option

87
New cards

What is the last option for severe Crohn's disease treatment?

Ustekinumab.

Explore top notes

note
Implications of wider issue
Updated 611d ago
0.0(0)
note
The German Revolution (1918-1919)
Updated 842d ago
0.0(0)
note
Chapter 20: Carbohydrates
Updated 1267d ago
0.0(0)
note
Traditional Music (AQA)
Updated 633d ago
0.0(0)
note
Transport in Plants
Updated 899d ago
0.0(0)
note
Implications of wider issue
Updated 611d ago
0.0(0)
note
The German Revolution (1918-1919)
Updated 842d ago
0.0(0)
note
Chapter 20: Carbohydrates
Updated 1267d ago
0.0(0)
note
Traditional Music (AQA)
Updated 633d ago
0.0(0)
note
Transport in Plants
Updated 899d ago
0.0(0)